GLUTATHIONE-S-TRANSFERASE GSTM1 NULL GENOTYPE IS NOT OVERREPRESENTED IN AUSTRALIAN PATIENTS WITH NEVOID BASAL-CELL CARCINOMA SYNDROME OR SPORADIC MELANOMA

被引:22
|
作者
SHANLEY, SM
CHENEVIXTRENCH, G
PALMER, J
HAYWARD, N
机构
[1] Queensland Institute of Medical Research, Herston, Brisbane 4029
基金
英国医学研究理事会;
关键词
D O I
10.1093/carcin/16.8.2003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The GSTM1 gene on chromosome 1p encodes the carcinogen-detoxification enzyme, glutathione S-transferase (mu subclass), The homozygous null genotype at this locus has been associated with increased susceptibility to malignancy, including some skin cancers, One hundred and twenty-four Australian patients with sporadic melanoma and 62 with familial basal cell carcinomas (a feature of nevoid basal cell carcinoma syndrome, NBCCS) were examined for germline homozygous deletions of GSTM1 using multiplex polymerase chain reactions, The homozygous null genotype was not overrepresented in either those with a single melanoma or in the NBCCS cases, Nor did it significantly accelerate tumorigenesis in either group, Analyses of much larger sample sizes will be required to investigate the representation of the null genotype in patients with multiple melanoma primaries and in those with melanoma coexisting with other non-cutaneous malignancies.
引用
收藏
页码:2003 / 2004
页数:2
相关论文
共 50 条
  • [1] Glutathione s-transferase GSTM1 null genotype is not overrepresented in Irish patients with malignant melanoma.
    Murphy, M
    Mabruk, MJEMF
    Collins, S
    Leader, M
    Kay, E
    Murphy, GM
    JOURNAL OF PATHOLOGY, 2001, 195 : 41A - 41A
  • [2] Glutathione S-transferase (GSTM1) null genotype and sulphonamide intolerance in acquired immunodeficiency syndrome
    Delomenie, C
    MathelierFusade, P
    Longuemaux, S
    Rozenbaum, W
    Leynadier, F
    Krishnamoorthy, R
    Dupret, JM
    PHARMACOGENETICS, 1997, 7 (06): : 519 - 520
  • [3] PHENOTYPE OF GLUTATHIONE-S-TRANSFERASE MU (GSTM1) AND SUSCEPTIBILITY TO MALIGNANT-MELANOMA
    LAFUENTE, A
    MOLINA, R
    PALOU, J
    CASTEL, T
    MORAL, A
    TRIAS, M
    MASCARO, JM
    VILALTA, A
    TRIAS, M
    PIULACHS, J
    BALLESTA, A
    ESTIVILL, X
    ESTAPE, J
    BRITISH JOURNAL OF CANCER, 1995, 72 (02) : 324 - 326
  • [4] GSTM1 NULL POLYMORPHISM AT THE GLUTATHIONE-S-TRANSFERASE M1 LOCUS - PHENOTYPE AND GENOTYPE STUDIES IN PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS
    DAVIES, MH
    ELIAS, E
    ACHARYA, S
    COTTON, W
    FAULDER, GC
    FRYER, AA
    STRANGE, RC
    GUT, 1993, 34 (04) : 549 - 553
  • [6] The glutathione-S-transferase mu 1 (GSTM1) null genotype and increased neutrophil response to low-level ozone (0.06 ppm)
    Alexis, Neil E.
    Lay, John C.
    Zhou, Haibo
    Kim, Chong S.
    Hernandez, Michelle L.
    Kehrl, Howard
    Hazucha, Milan J.
    Devlin, Robert B.
    Diaz-Sanchez, David
    Peden, David B.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : 610 - 612
  • [7] Glutathione-S-transferase (GSTM1, GSTT1) Null Phenotypes and Risk of Lung Cancer in a Korean Population
    Piao, Jin-Mei
    Shin, Min-Ho
    Kim, Hee Nam
    Cui, Lian-Hua
    Song, Hye-Rim
    Kweon, Sun-Seog
    Choi, Jin-Su
    Kim, Young-Chul
    Oh, In-Jae
    Kim, Kyu-Sik
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (12) : 7165 - 7169
  • [8] Increased frequencies of glutathione-S-transferase (GSTM1 and GSTT1) null genotypes in Indian patients with chronic myeloid leukemia
    Bajpai, Prachi
    Tripathi, Anil Kumar
    Agrawal, Deepa
    LEUKEMIA RESEARCH, 2007, 31 (10) : 1359 - 1363
  • [9] No differences in the glutathione S-transferase GSTM1 genotype between Irish patients with malignant melanoma and normal controls
    Murphy, M
    Mabruk, MJEMF
    Collins, S
    Leader, M
    Kay, E
    Murphy, GM
    JOURNAL OF PATHOLOGY, 2002, 198 : 56A - 56A
  • [10] POLYMORPHISM AT THE GLUTATHIONE-S-TRANSFERASE GSTM1 LOCUS - A STUDY OF THE FREQUENCIES OF THE GSTM1-A, GSTM1-B, GSTM1-A/B AND NULL PHENOTYPES IN NIGERIANS
    ZHAO, L
    ALLDERSEA, J
    FRYER, A
    TIGHE, A
    OLLIER, B
    THOMSON, W
    JONES, P
    STRANGE, R
    CLINICA CHIMICA ACTA, 1994, 225 (01) : 85 - 88